Abstract:
Despite high metabolic activity, the retina and optic nerve head lack traditional lymphatic drainage. We here identified a novel ocular glymphatic clearance route for fluid and wastes via the proximal optic nerve. Amyloid-β (Aβ) was cleared from the vitreous via a pathway driven by the ocular-cranial pressure difference. After traversing the lamina 5 barrier, intra-axonal Aβ was cleared via the perivenous space and subsequently drained to lymphatic vessels. Light-induced pupil constriction enhanced, while atropine or raising intracranial pressure blocked efflux. In two distinct murine models of glaucoma, Aβ leaked from the eye via defects in the lamina barrier instead of directional axonal efflux. The discovery of a novel pathway for removal of fluid and metabolites 10 from the intraocular space prompts a reevaluation of the core principles governing eye physiology and provides a framework for new therapeutic approaches to treat common eye diseases, including glaucoma.
Main Text:
Like the brain inside the cranial vault, the internal structures of the eye are contained within a confined space, which necessitates tight control of fluid homeostasis. Yet, both the eye and brain are largely devoid of traditional lymphatic vessels, which are critical for the clearance of fluid and solutes from peripheral tissues (1, 2). Recent discoveries 5 have shown that the brain possesses a quasi-lymphatic system, termed the glymphatic system (3) , and that traditional lymphatic vessels are also present in the dura mater, one of three layers of fibrous membranes lining the exterior surface of the brain (4, 5). In the brain, glymphatic/lymphatic transport contributes to clearing of amyloid-β (Aβ), a derivative of amyloid precursor protein (APP) that is one of the main constituents of 10 amyloid plaques in the brain (6) and likewise of amyloid deposits in the retina (7). In the eye, several hypothesis-driven investigations have pointed to the existence of an ocular glymphatic system (8-10). Experimental data have supported this concept by demonstrating retrograde cerebrospinal fluid (CSF) transport along the perivascular spaces in the optic nerve (11). Since the highly metabolically active neural tissues of the 15 retina produce Aβ (3, 12) and other potentially neurotoxic protein cleavage products like tau (13), we explicitly sought evidence of an intraocular anterograde glymphatic/lymphatic clearance system. First, we injected HiLyte-594-tagged human amyloid-β (hAβ) into the vitreous body of mice and visualized tracer distribution one hour later. Then we used uDISCO whole-body clearing (14) to analyze the eye and 20 tracer in see-through mouse heads. Surprisingly, three-dimensional reconstruction of light-sheet microscopy data revealed that hAβ tracer exited the eye along the optic nerve ( Fig. 1A, fig. S1A ). Transport along the optic nerve also occurred following non-invasive intravascular delivery of either the radiolabeled K + -analogue ( 86 Rb) or FITCcadaverine, a tracer that is permeable to the retinal-blood barrier, but not the bloodbrain barrier (15, 16) ( fig. S1B-D) . Whole-mount preparation of the optic nerve confirmed that hAβ tracer is transported anterograde along the optic nerve ( Fig. 1B) .
Moreover, use of reporter mice in which arteries and arterioles can be identified by 5 DsRed expression in mural cells revealed that hAβ tracer preferentially accumulated in the perivascular space along the optic nerve veins, rather than along arterioles (Fig.   1C ). In contrast to hAβ tracer, Alexa Fluor (AF)-dextran (3, 10, and 500 kDa) did not enter the optic nerve after intravitreal administration ( Fig. 1D, fig. S1E ). Sectioning and high-resolution imaging of the optic nerve showed that in addition to perivenous 10 accumulation, hAβ tracer was also transported along neuron-specific Class III β-tubulin (TUJ1)-positive axons, consistent with rapid neuronal uptake of hAβ (17) ( Fig. 1 E-F) .
Glial cells of the oligodendrocytic (Olig2 + ) and the astrocytic (Glt-1 + ) lineage also exhibited sparse hAβ tracer uptake ( fig. S2A-C) . The hAβ tracer accumulation peaked 260 ± 17 µm (mean ± SEM) from the optic nerve head and tapered off gradually in the 15 distal nerve, suggesting that hAβ tracer must exit the optic nerve anterior to the optic chiasm. This notion was supported by the observation that the dural sheet surrounding the proximal segment of the optic nerve densely accumulated tracer ( Fig. 1E) .
Additional analysis revealed traditional lymphatic vessels that were embedded in the dural sheath and surrounding loose tissue ( fig. S2D-F) . These vessels did not contain 20 red blood cells or stain with intravascularly-delivered lectin, but they labeled positive for the conventional lymphatic markers, lymphatic vessel endothelial hyaluronan receptor 1 (LYVE-1), vascular endothelial growth factor receptor 3 (VEGFR3) and podoplanin (PDPN) (2, 5) . Imaging after dual injections of hAβ tracer in the vitreous body in conjunction with AF-dextran (10 kDa) in the cisterna magna (CM) highlighted that the tracers were transported within the optic nerve in both anterograde and retrograde directions with limited spatial overlap ( Fig. 1H-I) . As reported previously, tracers injected in the CM were transporter along perivascular spaces (11). Use of reporter mice with 5 DsRed expression in mural cells revealed that CM-injected tracers were predominantly transported along the periarterial and pericapillary spaces ( Fig. 1J, fig. S2H ), in contrast to the intravitreal tracers, which accumulated along the veins (Fig. 1C) .
Collectively, these observations show that hAβ is transported by axons and along the perivenous space in the metabolically vulnerable (unmyelinated) initial segment of the 10 optic nerve (18) after intravitreal delivery. From there, hAβ exits the optic nerve via dural lymph vessels located in the outer layer of meninges lining the optic nerve and orbital lymphatics, as recently reported (19) . In support of this model, hAβ had accumulated in the ipsilateral cervical lymph nodes in animals examined three hours after intravitreal injection (2) ( Fig. 1G, fig. S2G ). 15 Pressure difference is a principal driving force of directional fluid transport. Since IOP under physiological conditions exceeds intracranial pressure (ICP), it is possible that the pressure difference across the lamina cribrosa contributes to fluid flow along the optic nerve (20). To define the role of the translaminar pressure difference in transport of hAβ tracer, we manipulated ICP by either withdrawal or injection of artificial CSF in 20 the CM while recording ICP ( Fig. 2A) . Decreasing intracranial pressure from the baseline level of 3.6 ± 0.4 mmHg to 0.5 ± 0.2 mmHg was linked to a sharp increase in the total hAβ tracer signal and the peak intensity of hAβ tracer transport in the proximal optic nerve 30 min after intravitreal injection ( Fig. 2B-E) . Conversely, increasing ICP to 16 .7 ± 0.6 mmHg ( Fig. 2A) blocked hAβ tracer transport in the optic nerves ( Fig. 2B-E) .
These data show that hAβ tracer transport along the optic nerve is sensitive to manipulation of the translaminar pressure gradient.
Prior observations have shown that repeated constriction of the pupil and ciliary 5 body during accommodation enhances aqueous outflow in healthy human subjects, hypothesized to be via trabecular and uveoscleral routes (21, 22) . We next asked whether the transport of hAβ along the optic nerve is influenced by physiological pupil constriction in vivo. To address this question, we compared transport of hAβ tracer in mice stimulated with light at 1 Hz to control mice kept in darkness. A subset of mice 10 exposed to light stimulation received atropine (1%, eye drops) to block the light-induced pupillary constriction reflex, while another subset of mice received pilocarpine (2%, eye drops) to achieve static constriction without light stimulation (Fig. 3A) . The analysis showed that light stimulation increased hAβ transport in the optic nerve. The total hAβ tracer signal, peak intensity, and distance of transport were all sharply increased by light 15 stimulation at 30 min after hAβ administration ( Fig. 3B-D) . Tracer accumulation in mice kept in darkness increased slowly and reached the same amplitude as that in the light- Fig. 3E-G) . Atropine completely blocked the light-induced pupil constriction, as well as the light-related acceleration of hAβ tracer transport ( Fig. 3 B-G) , while pilocarpineinduced tonic pupillary constriction did not appear to affect transport (Fig 3 B-D) .
Intravitreal hAβ tracer was not transported postmortem ( Fig. 3B, fig. S4B and F), suggesting that passive diffusion only insignificantly contributes to hAβ tracer dispersion along the optic nerve. These data suggest that repeated pupil and potentially ciliary increase IOP over a 1-month period, and secondarily cause RGC loss in non-pigmented CD-1 mice (26) . Our analysis of young DBA/2J mice showed that neither IOP nor hAβ tracer transport along the optic nerve differed from that in the D2-Gpnmb + (D2-control) mice, a genetically-matched control strain that does not develop ocular hypertension ( Fig. 4A and B, fig S7D) . About 50% of DBA/2J mice are severely affected by glaucoma at 11 months, but IOP is usually normalized or only mildly elevated at this 5 stage of the disease and thus less likely to directly influence tracer outflow (24) .
Surprisingly, using whole-mounts of optic nerve, we found that hAβ tracer transport was sharply increased in an equivalent subset of 11-month-old DBA/2J mice ( Fig. 4A-D, fig.   S6A -D), with total hAβ tracer signal significantly increased in 11-month-old DBA/2J mice compared with age-matched D2-control mice (Fig. 4B-D) . Similarly, we found that CD-1 10 CLS but not sham control mice exhibited significantly increased hAβ tracer transport one month after surgery, when IOP had normalized (26) ( Fig. 4B-D, fig. S6E ). Highresolution confocal imaging of 11-month-old DBA/2J optic nerves revealed that hAβ tracer was located primarily in the perivascular space, or outside the RGC axons, as opposed to the intra-axonal distribution noted in age-matched D2-control and young 15 DBA/2J mice (Fig. 1F, fig. S7A, fig. S6B ). This prompted us to ask whether the glial lamina normally acts as a high-resistance barrier that hinders transport of macromolecules. If so, then a corollary of this proposition would be that a failure of the lamina barrier might be one of the hallmarks of glaucoma (27, 28) . To test this dual hypothesis, we assessed the passage of increasing molecular sizes of AF-dextran 20 across the lamina following intravitreal injection in D2-control and DBA/2J mice (3, 10, 500 kDa), as well as CLS and sham control CD-1 mice (500 kDa). We found that even the smallest dextran (3 kDa, compared to 4.3 kDa for hAβ40) failed to pass the glial lamina in the D2 and CD-1 control mice (Fig. 1D, Fig. 4E, fig. S6G-L) . In contrast, we saw significant dispersion of all molecular sizes of dextran in 11-month-old DBA/2J and CLS mice, with tracer being detectable several mm distal to the lamina ( Fig. 4E-H, fig.   S6B-L) . Confocal imaging confirmed that the dextrans were present in the perivascular space, or outside the few remaining axons in 11-month-old DBA/2J mice ( fig. S7B-D (Fig. 4I, fig. S7G ). We also tested the alternative hypothesis that there could be a general expansion of the extracellular space volume fraction in response to axonal loss in old DBA/2J mice. Such an increase in extracellular space of the optic nerve would be expected to facilitate pressure driven- 15 hAβ transport. However, real-time TMA + electrophoretic analysis failed to confirm this hypothesis; the mean volume fraction (α) was ~10% of the total volume and did not differ between D2-control mice and DBA/2J mice ( Fig. 4J-K) . The tortuosity factor (λ) exhibited a non-significant trend toward reduction in old DBA/2J, perhaps reflecting axonal loss (31) (Fig. 4J) . 20 The demonstration of an ocular glymphatic clearance system driven by the translaminar pressure gradient raises several questions. For example, is the ocular glymphatic system the principal clearance route for protein metabolites such as Aβ S8B) . It is therefore possible that abnormal transport of APP/Aβ or other metabolites driven by the increase in translaminar pressure contributes to the degeneration of RGC axons at the early stages of glaucoma or following optic nerve injury (36, 37). Also, we 15 predict that the pathological increase in extracellular ocular fluid fluxes along the optic nerve in later-stage glaucoma triggers additional stress in the form of both heightened metabolic demands and loss of essential cytosolic components, such as vitamin B3 (38).
Conversely, our data suggest that the increased ICP and papilloedema of the optic nerve head observed in patients with idiopathic intracranial hypertension and in 20 astronauts after long-duration in microgravity (39, 40) would directly inhibit ocular glymphatic transport. Taken together, our analysis provides the first evidence for the existence of a highly polarized ocular glymphatic clearance system, an entirely new drainage pathway of the eye with profound implications for our understanding of eye health and disease.
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